Türkçe
English
There was a time when health debates, and the trillion-dollar research built around them, revolved around a single question: how much can human life be extended? Today the direction of the debate has changed. The real issue is no longer the length of life, but how those years are lived…
Today, this is the real question:
Is it “How long will I live” or “How will I live”?
There was a time when health debates, and the trillion-dollar research built around them, revolved around a single question: how much can human life be extended? Today the direction of the debate has changed. The real issue is no longer the length of life, but how those years are lived…
In recent years, the concept of sustainability has settled at the center of almost every sector. In the world of health, this concept has taken on a new dimension: sustainable healthy aging.
The point is no longer simply living longer. Being able to run a marathon at 70, remaining productive at 80, even sustaining life with the energy of one’s twenties… the debate is increasingly shifting toward this.
This perspective has made two more concepts visible in the health literature: “aging well” and “longevity.”
At first glance they look quite similar. Both aim for a healthier and longer human life. But there are important differences between them in terms of methods, clinical approaches and scientific foundations.
Today, researchers, clinics and health centers in many parts of the world are actually chasing the same question: how can people live not just longer, but better?
Longevity clinics, whose numbers have grown rapidly in recent years, are trying to approach this question from a more technological and innovative perspective. Longevity medicine’s claim is quite bold: to slow biological aging and optimize human performance. These centers typically carry out extensive biomarker panels, metabolic analyses, and epigenetic or biological age measurements. Personalized nutrition and exercise plans are prepared, and work is done on hormone balance.
At some centers, more experimental applications also come into play. Intravenous infusions containing NAD+ or micronutrients, senolytic therapies (an experimental drug approach aiming to target and eliminate “zombie” cells that cause tissue damage), or plasma exchange methods can be part of these programs. The scientific background of this approach lies in a research field called “geroscience,” which studies the biological mechanisms of aging. Scientists working in this field believe that by targeting aging processes, many age-related diseases such as heart disease, diabetes or Alzheimer’s could be delayed.
To continue reading;
https://www.forbes.com.tr/yazar/meri-istiroti
